These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 7977422)

  • 1. Extended dosage intervals for aminoglycosides.
    Rodman DP; Maxwell AJ; McKnight JT
    Am J Hosp Pharm; 1994 Aug; 51(16):2016-21. PubMed ID: 7977422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy.
    Periti P
    J Chemother; 1995 Aug; 7(4):311-37. PubMed ID: 8568543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tobramycin--clinical pharmacology and chemotherapy].
    Periti P
    J Chemother; 1996 Jan; 8 Suppl 1():3-30. PubMed ID: 8948764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single daily dosing of aminoglycosides.
    Preston SL; Briceland LL
    Pharmacotherapy; 1995; 15(3):297-316. PubMed ID: 7667165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Once-daily versus multiple-daily dosing of aminoglycosides.
    Craig WA
    J Chemother; 1995 Jun; 7 Suppl 2():47-52. PubMed ID: 8622110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Daily single-dose aminoglycoside administration. Therapeutic and economic benefits].
    Knudsen LM; Frimodt-Møller N; Hansen MT; Hippe E
    Ugeskr Laeger; 1993 May; 155(19):1436-41. PubMed ID: 8316969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the evidence for once-daily aminoglycoside therapy?
    Barclay ML; Begg EJ; Hickling KG
    Clin Pharmacokinet; 1994 Jul; 27(1):32-48. PubMed ID: 7955770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
    Prescott WA; Nagel JL
    Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Once-daily dosage of aminoglycosides--a therapeutic simplification and an economical benefit].
    Berild D; Sjursen H; Digranes A
    Tidsskr Nor Laegeforen; 1999 Sep; 119(21):3152-6. PubMed ID: 10522483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of aminoglycosides once-a-day: experimental and clinical data.
    Tulkens PM
    Scand J Infect Dis Suppl; 1990; 74():249-57. PubMed ID: 2097713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
    Graham AC; Mercier RC; Achusim LE; Pai MP
    Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of aminoglycoside therapy: a single daily dose.
    Deamer RL; Dial LK
    Am Fam Physician; 1996 Apr; 53(5):1782-6. PubMed ID: 8623702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aminoglycoside-induced nephrotoxicity].
    Fabrizii V; Thalhammer F; Hörl WH
    Wien Klin Wochenschr; 1997 Nov; 109(21):830-5. PubMed ID: 9454436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Back to the future: using aminoglycosides again and how to dose them optimally.
    Drusano GL; Ambrose PG; Bhavnani SM; Bertino JS; Nafziger AN; Louie A
    Clin Infect Dis; 2007 Sep; 45(6):753-60. PubMed ID: 17712761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring.
    Croes S; Koop AH; van Gils SA; Neef C
    Eur J Pharm Sci; 2012 Jan; 45(1-2):90-100. PubMed ID: 22094306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoglycoside nephrotoxicity.
    Swan SK
    Semin Nephrol; 1997 Jan; 17(1):27-33. PubMed ID: 9000547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycosides: a practical review.
    Gonzalez LS; Spencer JP
    Am Fam Physician; 1998 Nov; 58(8):1811-20. PubMed ID: 9835856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dosing aminoglycosides once a day].
    Blaser J
    Schweiz Med Wochenschr Suppl; 1996; 76():39S-48S. PubMed ID: 8677418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.